These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
490 related items for PubMed ID: 22007930
1. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. Lu KC, Ma WY, Yu JC, Wu CC, Chu P. Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930 [Abstract] [Full Text] [Related]
2. Parathyroidectomy leads to decreased blood lead levels in patients with refractory secondary hyperparathyroidism. Chu P, Wu CC, Chen CC, Lu KC. Bone; 2012 May; 50(5):1032-8. PubMed ID: 22373954 [Abstract] [Full Text] [Related]
3. Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. Zheng CM, Chu P, Wu CC, Ma WY, Hung KC, Hsu YH, Lin YF, Diang LK, Lu KC. Tohoku J Exp Med; 2012 Jan; 226(1):19-27. PubMed ID: 22156488 [Abstract] [Full Text] [Related]
4. Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism. Ma L, Zhao S, Li Z. Scand J Clin Lab Invest; 2017 Nov; 77(7):527-534. PubMed ID: 28741963 [Abstract] [Full Text] [Related]
5. Serum bone resorption markers after parathyroidectomy for renal hyperparathyroidism: correlation analyses for the cross-linked N-telopeptide of collagen I and tartrate-resistant acid phosphatase. Hung KC, Huang CY, Liu CC, Wu CJ, Chen SY, Chu P, Wu CC, Lo L, Diang LK, Lu KC. ScientificWorldJournal; 2012 Nov; 2012():503945. PubMed ID: 22919331 [Abstract] [Full Text] [Related]
6. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease. Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N. Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964 [Abstract] [Full Text] [Related]
7. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism. Lu KC, Tseng CF, Wu CC, Yeung LK, Chen JS, Chao TY, Janckila AJ, Yam LT, Chu P. Blood Purif; 2006 Dec; 24(5-6):423-30. PubMed ID: 16888370 [Abstract] [Full Text] [Related]
8. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M, Fukunaga M, Ohtawa T, Harada T. World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [Abstract] [Full Text] [Related]
9. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain. Yano S, Sugimoto T, Tsukamoto T, Yamaguchi T, Hattori T, Sekita KI, Kaji H, Hattori S, Kobayashi A, Chihara K. Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370 [Abstract] [Full Text] [Related]
10. Serum fetuin-A levels increased following parathyroidectomy in uremic hyperparathyroidism. Wang CC, Hsu YJ, Wu CC, Yang SS, Chen GS, Lin SH, Chu P. Clin Nephrol; 2012 Feb; 77(2):89-96. PubMed ID: 22257538 [Abstract] [Full Text] [Related]
11. Decreased blood lead levels after calcitriol treatment in hemodialysis patients with secondary hyperparathyroidism. Lu KC, Wu CC, Ma WY, Chen CC, Wu HC, Chu P. Bone; 2011 Dec; 49(6):1306-10. PubMed ID: 21985997 [Abstract] [Full Text] [Related]
12. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Ge Y, Yang G, Wang N, Zha X, Yu X, Mao H, Sun B, Zeng M, Zhang B, Xing C. Int Urol Nephrol; 2019 Aug; 51(8):1443-1449. PubMed ID: 31264087 [Abstract] [Full Text] [Related]
13. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism. Chou FF, Chen JB, Lee CH, Chen SH, Sheen-Chen SM. Arch Surg; 2001 Sep; 136(9):1064-8. PubMed ID: 11529832 [Abstract] [Full Text] [Related]
14. Influence of Parathyroidectomy on Bone Metabolism and Bone Pain in Patients with Secondary Hyperparathyroidism. Schneider R, Steinmetz C, Karakas E, Bartsch DK, Schlosser K. Eur Surg Res; 2018 Sep; 59(1-2):35-47. PubMed ID: 29393259 [Abstract] [Full Text] [Related]
15. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis. Negri AL, Barone R, Quiroga MA, Bravo M, Marino A, Fradinger E, Bogado CE, Zanchetta JR. Perit Dial Int; 2004 Sep; 24(2):163-8. PubMed ID: 15119637 [Abstract] [Full Text] [Related]
16. Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism. Fang L, Wu J, Luo J, Wen P, Xiong M, Cao J, Chen X, Yang J. BMC Nephrol; 2018 Jun 15; 19(1):142. PubMed ID: 29907149 [Abstract] [Full Text] [Related]
17. Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience. Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, Chang JF, Chen HY. Blood Purif; 2013 Jun 15; 36(2):116-21. PubMed ID: 24217122 [Abstract] [Full Text] [Related]
18. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients. Jeong JU, Lee HK, Kim YJ, Kim JS, Kang SS, Kim SB. Clin Nephrol; 2010 Nov 15; 74(5):336-42. PubMed ID: 20979940 [Abstract] [Full Text] [Related]
19. Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K. J Clin Endocrinol Metab; 2000 May 15; 85(5):1901-7. PubMed ID: 10843172 [Abstract] [Full Text] [Related]
20. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism. Moldovan D, Racasan S, Kacso IM, Rusu C, Potra A, Bondor C, Patiu IM, Gherman-Căprioară M. Int Urol Nephrol; 2015 Nov 15; 47(11):1871-7. PubMed ID: 26377492 [Abstract] [Full Text] [Related] Page: [Next] [New Search]